Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death

Detalles Bibliográficos
Autores principales: Williams, Mark D, Janes, Jonathan M, Nelson, David R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751048/
https://www.ncbi.nlm.nih.gov/pubmed/17094791
http://dx.doi.org/10.1186/cc5062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751048/
https://www.ncbi.nlm.nih.gov/pubmed/17094791
http://dx.doi.org/10.1186/cc5062

Ejemplares similares